Scholar Rock Holding (STU:2QK) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 12, 2026)


STU:2QK Scholar Rock Holding Corp STU:2QK
45 GF Score
Price €49.57
GF Value €24.41
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Scholar Rock Holding Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Scholar Rock Holding's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

STU:2QK vs COGT, CGON, PTCT: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Scholar Rock Holding's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scholar Rock Holding Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Scholar Rock Holding's Margin of Safety % (DCF FCF Based) falls into.


STU:2QK
45GF Score
Scholar Rock Holding Corp STU:2QK
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Scholar Rock Holding (STU:2QK) Overvalued in 2026?

Based on GuruFocus' analysis, Scholar Rock Holding stock appears to be overvalued. The current stock price of €49.57 is trading 103.1% above its estimated GF Value™ of €24.41. GuruFocus considers Scholar Rock Holding to be Significantly Overvalued.

Key valuation signals for STU:2QK:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €24.41 vs. price of €49.57 (103.1% above fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the STU:2QK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scholar Rock Holding Business Description

Other Exchanges SRRK:USA
Address 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
45GF Score

Get the complete analysis for STU:2QK

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.57
Price
€24.41
GF Value